According to @ai_darpa, researchers have introduced "Circulatronics," a breakthrough technique that integrates AI-driven wireless microdevices with living immune cells to enable targeted, non-invasive brain repair. These gadgets, described in Nature Biotechnology (source: nature.com/articles/s41587-025-02809-3), harvest light energy and travel through the bloodstream, using immune cells as carriers. This allows them to autonomously access inflamed brain regions without surgery and wirelessly stimulate neurons with micrometer accuracy, as demonstrated in mice. The innovation signals a major opportunity for AI-powered neuromodulation therapies, particularly for Alzheimer's, multiple sclerosis, stroke, brain tumors, and chronic pain, offering scalable and minimally invasive solutions for neurological diseases.

According to Greg Brockman (@gdb), ChatGPT has been applied to address a longstanding medical problem, showcasing its potential in clinical problem-solving and healthcare innovation (source: https://twitter.com/gdb/status/1941567568155902397). This development highlights the growing use of generative AI for medical diagnostics and research, providing opportunities for healthcare organizations to accelerate complex case analysis, improve diagnostic accuracy, and reduce time-to-treatment. With ChatGPT's integration in medical workflows, businesses in digital health and AI-driven healthcare services can capitalize on the trend of AI-powered clinical decision support, paving the way for enhanced patient outcomes and operational efficiency.